Crosstalk with hypoxia-inducible factors (e.g., HIF-2α) has also been shown to amplify PXR-mediated transcription of drug resistance genes such as CYP3A4, which further complicates therapeutic outcomes in cancer. This evidence concerns the gene CYP3A4 and cancer.